RecruitingNot Applicable

Effect of SugarLock® Peanut Skin Extract on Postprandial Blood Glucose Control

Taiwan30 participantsStarted 2026-07-09

Plain-language summary

The objective of this study is to investigate the effects of pre-meal supplementation with SugarLock® peanut skin extract and white kidney bean extract on reducing or delaying postprandial blood glucose elevation and glycemic fluctuations, and to evaluate their potential as nutritional supplements for postprandial glycemic management.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18 years or older; * Fasting blood glucose level \< 100 mg/dL; * Individuals without type 1 or type 2 diabetes. Exclusion Criteria: * Women who are pregnant, breastfeeding, or planning to become pregnant during the study period; * Individuals with chronic gastrointestinal diseases (such as irritable bowel syndrome \[IBS\], inflammatory bowel disease \[IBD\], chronic diarrhea, celiac disease, short bowel syndrome, ulcers, colorectal cancer, etc.), a history of epilepsy or seizures, psychiatric disorders, malignant tumors, endocrine disorders, liver or kidney disease, or other major organic diseases; * Individuals with a history of gastrointestinal surgery or organ transplantation; * Individuals who have taken medications or supplements affecting blood glucose or insulin within the past three months; * Individuals allergic to peanuts or white kidney beans; * Full-time employees in the same department as the principal investigator, and students directly taught by the principal investigator during the current semester.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Interstitial fluid glucose level (mg/dL)

Timeframe: at 3 hours after eating white rice

Trial details

NCT IDNCT07705191

SponsorTCI Co., Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-09-30

Contact for this trial

Fang-Pei Chen, Ph.D.

+886-06-2785123 fpchen@mail.cjcu.edu.tw

View on ClinicalTrials.gov More Blood Sugar (Glucose) Control trials